MSLN and neoplasm: To overcome the relative lack of cancer neoantigens in KPC and other models of PDAC, studies have utilized the expression of xenoantigens such as ovalbumin or murine mesothelin to successfully study the impact of tumor antigenicity on the tumor stroma and T cell-mediated immune response in the KPC model [38, 41, 42].